MULTICENTER STUDY INVESTIGATING THE IMPACT OF DEEP LEARNING-BASED UIP CLASSIFIER ON IDENTIFYING UNDIAGNOSED IPF AND NON-IPF PROGRESSIVE PULMONARY FIBROSIS

被引：0
|
作者：
Patel, Avignat
Bhatt, Padmanabh
Thomas, Richard
Hoang, Hai
Aglan, Mostafa
Ahmed, Alaaeldin
Arora, Shreya
Vaz, Victor Ren
Guillen, Ramon
Wald, Christoph
Rieger-Christ, Kimberly
Liesching, Timothy N.
Pinto-Plata, Victor M.
Thomson, Carey C.
Gazourian, Lee
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6398A / 6399A
页数：2
相关论文
共 17 条
  • [1] Multicenter real-world data of antifibrotics in non-IPF progressive pulmonary fibrosis (PPF) patients
    Ocal, Nesrin
    Cilli, Aykut
    Bishop, Nesrin Mogulkoc
    Coskun, Funda
    Ursavas, Ahmet
    Hanta, Ismail
    Ozyurek, Berna Akinci
    Ensarioglu, Kerem
    Erzincan, Alper
    Yuksel, Esra
    Arikan, Beste
    Uzer, Fatih
    Ozdemirel, Tugce Sahin
    Misirci, Salim
    Deniz, Pelin Pinar
    Basyigit, Ilknur
    Kumbasar, Ozlem Ozdemir
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Real-world of Nintedanib in a Spanish non-IPF progressive pulmonary fibrosis cohort
    Vicens Zygmunt, Vanesa
    Bordas-Martinez, Jaume
    Munoz-Bolano, Miriam
    Carmezim-Correia, Joao
    Belen Llanos-Gonzalez, Ana
    Domingo-Carnice, Adria
    Rodriguez-Cumplido, Dolores
    Bermudo-Peloche, Guadalupe
    Tebe-Cordomi, Cristian
    Llop-Rius, Roser
    Molina-Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis
    Philipp Markart
    Der Pneumologe, 2020, 17 (5): : 350 - 351
  • [4] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [5] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [6] IN NON-IPF FIBROSING ILD, E-LUNG BIOMARKERS ARE ASSOCIATED WITH THE FUTURE DEVELOPMENT OF PROGRESSIVE PULMONARY FIBROSIS INDEPENDENT OF UIP STATUS ON CT SCAN
    George, Peter
    Rennison-Jones, Christian
    Ottink, Finja
    Baggs, Rachel
    Sifostratoudaki, Aliki
    Fernandez, Claire
    Gerry, Stephen
    Harston, George
    Devaraj, Anand
    CHEST, 2024, 166 (04) : 3264A - 3265A
  • [7] A real-life cohort of antifibrotic-treated non-IPF progressive pulmonary fibrosis patients
    Renner, A.
    Vertanen, E.
    Sutinen, E.
    Ainola, M.
    Myllaerniemi, M.
    Hollmen, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S552 - S552
  • [8] Longitudinal Comparison of Anxiety and Depression Between Idiopathic Pulmonary Fibrosis (IPF) and Non-IPF Interstitial Lung Disease: A Prospective Cohort Study
    Bae, W.
    Cho, J.
    Lee, J.
    Park, Y.
    Lee, C.
    Lee, S.
    Yim, J.
    Yoo, C.
    Kim, Y.
    Han, S.
    Choi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
    Raman, Lavanya
    Stewart, Iain
    Barratt, Shaney L.
    Chua, Felix
    Chaudhuri, Nazia
    Crawshaw, Anjali
    Gibbons, Michael
    Hogben, Charlotte
    Hoyles, Rachel
    Kouranos, Vasilis
    Martinovic, Jennifer
    Mulholland, Sarah
    Myall, Katherine J.
    Naqvi, Marium
    Renzoni, Elisabetta A.
    Saunders, Peter
    Steward, Matthew
    Suresh, Dharmic
    Thillai, Muhunthan
    Wells, Athol U.
    West, Alex
    Mitchell, Jane A.
    George, Peter M.
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [10] Deep Learning-Based Prediction of Progressive Fibrotic Lung Disease on Baseline Computed Tomography in the Australian IPF Registry
    Jo, H.
    Corte, T. J.
    Calandriello, L.
    Silva, M.
    Sverzellati, N.
    Chapman, S.
    Cooper, W.
    Ellis, S.
    Glaspole, I.
    Goh, N.
    Grainge, C.
    Hopkins, P.
    Keir, G. J.
    Maher, A.
    Moodley, Y. I.
    Reynolds, P. N.
    Walters, E. H.
    Leigh, L.
    Oldmeadow, C.
    Humphries, S. M.
    Lynch, D. A.
    Walsh, S. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12